Clinical Thyroidology® for the Public
Summaries for the Public from recent articles in Clinical Thyroidology
Table of Contents | PDF File for Saving and Printing
THYROID CANCER
Am I supposed to decide my thyroid cancer treatment?
Clinical Thyroidology® for the Public
Summaries for the Public from recent articles in Clinical Thyroidology
Table of Contents | PDF File for Saving and Printing
THYROID CANCER
Am I supposed to decide my thyroid cancer treatment?
BACKGROUND
Shared decision making is a process in which both the patient and their doctor work together to decide the best plan of care for the patient. Often, shared decision making is more complicated than getting permission for a procedure or making a medical decision. The patient and physician know that a decision needs to be made, so the physician collects and presents prior studies and data about treatment options and takes into consideration the patient’s wishes for the final medical decision. Shared decision making is the standard of care in cancer settings. It is especially important in the field of thyroid cancer, since less invasive treatment methods are being recommended with recent guidelines. Even though making clinical decisions with the input of patient’s decisions is standard of care, this practice can be hard to observe, measure, and compare.
The goal of this study was to see if communication training by physicians and decision aids for patients helped with the practice of shared decision making.
THE FULL ARTICLE TITLE
Koot A et al. Effect of a patient decision aid on shared decision making in patients with differentiated thyroid cancer: a randomized controlled trial. Oncologist 2026;31(5)
SUMMARY OF THE STUDY
A total of 26 physicians (8 endocrinologists, 6 oncologists (cancer doctors), and 12 surgeons) underwent 5 hours of communications training, then they performed visits with patients. The patients were divided into 2 groups: one group who reviewed online patient decision aids prior to the discussion with the physician and the other group who did not have access to these online decision aids. All patients had their care previously discussed in thyroid tumor boards, which are professional discussions with endocrinologists, oncologists, pathologists and surgeons. The patients were divided into 3 disease categories: 1) total thyroidectomy or lobectomy for low risk of recurrence thyroid cancer; 2) proceeding with completion thyroidectomy or continuing to monitor with lobectomy for low risk of recurrence thyroid cancer or 3) cessation of chemotherapy for more aggressive thyroid cancer.
The decision aids were guided by the International Patient Decision Aid Standards, and patients shared their responses with the physicians. From recordings of the visits, it was determined whether several treatment options were presented, a partnership was established, options were described, and patient’s preferred option were asked and incorporated into the ultimate medical treatment decision. In addition, it was determined whether the provider asked about patient’s general health and cancer worries, gained the trust of the patient, appeared to have both subjective and objective knowledge, and presented treatment options in a balanced way.
Overall, 38 visits included the decision aids and 40 did not. The decision aids did not appear to improve shared decision making. Although the communications training and decision aids did not improve shared decision making, patients prefered their use in their medical care. The weakest categories were forming a physician-patient partnership and using patient’s preference in the final medical decision in both groups of the study. Treatment preferences were voiced by 92% of patients, and 61% of those patients desired less aggressive treatment options. Of the patients who participated in the study, 82% felt as if the decision aids improved their knowledge, and all would recommend the decision aid to other patients.
WHAT ARE THE IMPLICATIONS OF THIS STUDY?
Even though making clinical decisions with the input of patient’s decisions is standard of care, there can be communication differences among physicians and patients. The physicians who participated in the study were likely motivated to practice shared decision making. Shared decision making is a quality measure in cancer care, and the communications training completed by the physicians might have been more useful than the decision aids used by the patients. Most patients felt as if the decision aids improved their knowledge, and all would recommend them to other patients.
—Pinar Smith, MD
ATA RESOURCES
Thyroid Cancer (Papillary and Follicular): https://www.thyroid.org/thyroid-cancer/
Older Patients and Thyroid Disease: https://www.thyroid.org/thyroid-disease-older-patient/
Thyroid Disease in Pregnancy: https://www.thyroid.org/thyroid-disease-pregnancy/
ABBREVIATIONS & DEFINITIONS
Differentiated thyroid cancer: the most common type of thyroid cancer, includes papillary, follicular and oncocytic thyroid cancer
Thyroidectomy: surgery to remove the entire thyroid gland. When the entire thyroid is removed it is termed a total thyroidectomy. When less is removed, such as in removal of a lobe, it is termed a partial thyroidectomy.
Lobectomy: surgery to remove one lobe of the thyroid.
Completion thyroidectomy: surgery to remove the remaining thyroid lobe in thyroid cancer patients who initially had a lobectomy.